Supporting the

Neuroendocrine Cancer Community

Sunitinib efficacy in Pheochromocytoma and Paraganglioma

Sep 24, 2021

#ESMO2021 Rare NETs: Sunitinib efficacy in #Pheochromocytoma and #Paraganglioma – “A strong result for a treatment based on sound mechanistic principle,” says Prof Juan Valle, University of Manchester & Dept of Medical Oncology at The Christie NHS Foundation Trust, Manchester, UK.

READ FULL REPORT HERE – https://dailyreporter.esmo.org/esmo-congress-2021/all-articles/rare-nets-sunitinib-shows-efficacy-in-pheochromocytoma-and-paraganglioma?hit=mail-gen

Presidential 3_NETs

Q&A session on NETs following the Presidential Symposium 3 (ESMO Congress 2021)